<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-13-21518</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0071338</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>Antigen-presenting cells</subject></subj-group></subj-group><subj-group><subject>Immunity</subject><subj-group><subject>Inflammation</subject><subject>Innate immunity</subject></subj-group></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Bacterial pathogens</subject><subj-group><subject>Gram negative</subject></subj-group></subj-group><subj-group><subject>Immunity</subject><subj-group><subject>Inflammation</subject><subject>Innate immunity</subject></subj-group></subj-group><subj-group><subject>Medical microbiology</subject><subject>Microbial pathogens</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Plasmacytoid Dendritic Cells Are Crucial in <italic>Bifidobacterium adolescentis</italic>-Mediated Inhibition of <italic>Yersinia enterocolitica</italic> Infection</article-title>
<alt-title alt-title-type="running-head">Plasmacytoid DCs during <italic>Yersinia</italic> Infection</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wittmann</surname><given-names>Alexandra</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Autenrieth</surname><given-names>Ingo B.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Frick</surname><given-names>Julia-Stefanie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Institute for Medical Microbiology and Hygiene, University Hospital Tübingen, Tübingen, Germany</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>German Centre for Infection Research, University of Tübingen, Tübingen, Germany</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Heimesaat</surname><given-names>Markus M.</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Charité, Campus Benjamin Franklin, Germany</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">julia-stefanie.frick@med.uni-tuebingen.de</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: AW IBA JSF. Performed the experiments: AW. Analyzed the data: AW JSF. Contributed reagents/materials/analysis tools: IBA JSF. Wrote the paper: AW JSF.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2013</year></pub-date>
<pub-date pub-type="epub"><day>20</day><month>8</month><year>2013</year></pub-date>
<volume>8</volume>
<issue>8</issue>
<elocation-id>e71338</elocation-id>
<history>
<date date-type="received"><day>22</day><month>5</month><year>2013</year></date>
<date date-type="accepted"><day>3</day><month>7</month><year>2013</year></date>
</history>
<permissions>
<copyright-year>2013</copyright-year>
<copyright-holder>Wittmann et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>In industrialized countries bacterial intestinal infections are commonly caused by enteropathogenic <italic>Enterobacteriaceae</italic>. The interaction of the microbiota with the host immune system determines the adequacy of an appropriate response against pathogens. In this study we addressed whether the probiotic <italic>Bifidobacterium adolescentis</italic> is protective during intestinal <italic>Yersinia enterocolitica</italic> infection. Female C57BL/6 mice were fed with <italic>B. adolescentis</italic>, infected with <italic>Yersinia enterocolitica</italic>, or <italic>B. adolescentis</italic> fed and subsequently infected with <italic>Yersinia enterocolitica. B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice were protected from <italic>Yersinia</italic> infection as indicated by a significantly reduced weight loss and splenic <italic>Yersinia</italic> load when compared to <italic>Yersinia</italic> infected mice. Moreover, protection from infection was associated with increased intestinal plasmacytoid dendritic cell and regulatory T-cell frequencies. Plasmacytoid dendritic cell function was investigated using depletion experiments by injecting <italic>B. adolescentis</italic> fed, <italic>Yersinia</italic> infected C57BL/6 mice with anti-mouse PDCA-1 antibody, to deplete plasmacytoid dendritic cells, or respective isotype control. The <italic>B. adolescentis</italic>-mediated protection from <italic>Yersinia</italic> dissemination to the spleen was abrogated after plasmacytoid dendritic cell depletion indicating a crucial function for pDC in control of intestinal <italic>Yersinia</italic> infection. We suggest that feeding of <italic>B. adolescentis</italic> modulates the intestinal immune system in terms of increased plasmacytoid dendritic cell and regulatory T-cell frequencies, which might account for the <italic>B. adolescentis</italic>-mediated protection from <italic>Yersinia enterocolitica</italic> infection.</p>
</abstract>
<funding-group><funding-statement>This work was supported by the ZEM (Zentrum für Ernährungsmedizin) and the BMBF (Bundesministerium für Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Infection with <italic>Yersinia enterocolitica</italic> e.g. by ingestion of contaminated food or drinking water can cause severe diarrhea, enterocolitis, and mesenteric lymphadenitis <xref ref-type="bibr" rid="pone.0071338-Bottone1">[1]</xref>, <xref ref-type="bibr" rid="pone.0071338-Cover1">[2]</xref>. <italic>Yersinia enterocolitica</italic> is a facultative anaerobic, pleomorphic, gram-negative rod that belongs to the family of <italic>Enterobacteriaceae</italic> and its enteropathogenicity is associated with the presence of a 70-kb virulence plasmid (pYV) that encodes a type three secretion system, translocated effector proteins, and the trimeric autotransporter <italic>Yersinia</italic> adhesin A (YadA) <xref ref-type="bibr" rid="pone.0071338-Cornelis1">[3]</xref>, <xref ref-type="bibr" rid="pone.0071338-Schindler1">[4]</xref>.</p>
<p>Several studies demonstrate that the host's intestinal microbiota is crucial in defining the host's susceptibility towards intestinal infections. This is demonstrated by the significant influence of antibiotic treatment on the composition of the intestinal microbiota, in both, human subjects <xref ref-type="bibr" rid="pone.0071338-DeLaCochetiere1">[5]</xref>, <xref ref-type="bibr" rid="pone.0071338-Dethlefsen1">[6]</xref>, <xref ref-type="bibr" rid="pone.0071338-Jernberg1">[7]</xref>, <xref ref-type="bibr" rid="pone.0071338-Lofmark1">[8]</xref> and mice <xref ref-type="bibr" rid="pone.0071338-Antonopoulos1">[9]</xref>, <xref ref-type="bibr" rid="pone.0071338-Yap1">[10]</xref> where increased susceptibility towards enteropathogenic bacteria was shown <xref ref-type="bibr" rid="pone.0071338-Sekirov1">[11]</xref>, <xref ref-type="bibr" rid="pone.0071338-Lupp1">[12]</xref>. The intestinal microbiota is thought to shape the innate immune system in different ways. It was demonstrated that antibiotic treatment of mice and subsequent alterations of the intestinal microbiota notably down-regulate the expression of Reg3γ, a secreted C-type lectin which kills gram-positive bacteria including e.g. antibiotic-resistant bacteria such as vancomycin resistant <italic>Enterococcus</italic> (VRE) <xref ref-type="bibr" rid="pone.0071338-Brandl1">[13]</xref>. The secretion of Reg3γ could be restored via stimulation of intestinal TLR4 thereby boosting the innate immune resistance of antibiotic-treated mice against infections with VRE <xref ref-type="bibr" rid="pone.0071338-Brandl1">[13]</xref>. In addition, antibiotic-induced disruption of the intestinal microbiota enhances the susceptibility of human hosts to infections with nontyphoidal <italic>Salmonellae</italic> <xref ref-type="bibr" rid="pone.0071338-Gradel1">[14]</xref>, and is a prerequisite for infection of mice with <italic>Salmonella typhimurium</italic> <xref ref-type="bibr" rid="pone.0071338-Barthel1">[15]</xref>, <xref ref-type="bibr" rid="pone.0071338-Frick1">[16]</xref>.</p>
<p>Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a beneficial effect on the health of the host <xref ref-type="bibr" rid="pone.0071338-Senok1">[17]</xref>. E. g. <italic>Lactobacillus rhamnosus</italic> GG, <italic>Bifidobacterium bifidum, Streptococcus thermophilus</italic> and <italic>Saccharomyces boulardii</italic> revealed a beneficial effect on children with rotavirus infections <xref ref-type="bibr" rid="pone.0071338-Gionchetti1">[18]</xref>, <xref ref-type="bibr" rid="pone.0071338-Weichert1">[19]</xref>, <xref ref-type="bibr" rid="pone.0071338-Canani1">[20]</xref>. Furthermore, several studies summarized by Nomoto <italic>et al.</italic> report a decrease in the incidence of antibiotic-induced diarrhea by administration of <italic>Saccharomyces boulardii</italic>, <italic>Lactobacillus rhamnosus</italic> GG, <italic>Bifidobacterium longum</italic> and <italic>Enterococcus faecium</italic> <xref ref-type="bibr" rid="pone.0071338-Nomoto1">[21]</xref>.</p>
<p>Dendritic cells (DCs) are essential initiators of immunity and link innate to adaptive antimicrobial immune responses <xref ref-type="bibr" rid="pone.0071338-Schlitzer1">[22]</xref>. In order to fulfill these tasks, first DC need to sample intestinal antigens. These are acquired by DC either in Peyer's patches, where M cells deliver luminal content by transcytosis <xref ref-type="bibr" rid="pone.0071338-Iwasaki1">[23]</xref>, <xref ref-type="bibr" rid="pone.0071338-Kraehenbuhl1">[24]</xref>, or DC can sample actively by extending dendrites into the lumen without disrupting epithelial tight junctions due to the expression of CX<sub>3</sub>CR1 <xref ref-type="bibr" rid="pone.0071338-Niess1">[25]</xref>. However, this subset of DC was demonstrated to be non-migratory whereas CD103-expressing intestinal DC migrate to the mesenteric lymph nodes in a big way after antigen acquisition, for which they rely on other cell types <xref ref-type="bibr" rid="pone.0071338-Bogunovic1">[26]</xref>. In the intestine conventional DC (cDC) are made up by these two subsets which both can additionally express CD11b <xref ref-type="bibr" rid="pone.0071338-Bogunovic1">[26]</xref> and occur in the lamina propria as well as the Peyer's patches <xref ref-type="bibr" rid="pone.0071338-Niess1">[25]</xref>, <xref ref-type="bibr" rid="pone.0071338-delRio1">[27]</xref>. In addition to cDC, plasmacytoid DC exist and are defined by their intermediate expression of CD11c and additional expression of PDCA-1 and B220 <xref ref-type="bibr" rid="pone.0071338-Wendland1">[28]</xref>. They are found to a minor extent in secondary lymphoid organs <xref ref-type="bibr" rid="pone.0071338-Villadangos1">[29]</xref> and the lamina propria but occur mainly in the intraepithelial compartment <xref ref-type="bibr" rid="pone.0071338-Wendland1">[28]</xref>. In response to TLR9 and TLR7 signalling pDCs produce high amounts of type I IFNs <xref ref-type="bibr" rid="pone.0071338-Bogunovic1">[26]</xref>. In addition, pDCs are thought to be of key importance for the regulation of tolerance and are considered to be inducers of regulatory T cells <xref ref-type="bibr" rid="pone.0071338-Baumgart1">[30]</xref>, <xref ref-type="bibr" rid="pone.0071338-Moseman1">[31]</xref>, <xref ref-type="bibr" rid="pone.0071338-Matta1">[32]</xref>.</p>
<p>In previous work we identified a probiotic <italic>B. adolescentis</italic> strain that attenuated the course of <italic>Y. enterocolitica</italic> infection in mice by reducing clinical symptoms, dissemination of <italic>Yersinia</italic>, and <italic>Y. enterocolitica</italic>-induced mucosal inflammation <xref ref-type="bibr" rid="pone.0071338-Frick2">[33]</xref>. In this study we demonstrate that feeding of viable <italic>B. adolescentis</italic> was associated with an increased number of PDCA-1-positive pDCs in the intestine and an attenuated course of <italic>Y. enterocolitica</italic> infection as indicated by reduced clinical symptoms and reduced dissemination of <italic>Yersinia.</italic></p>
</sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Mice</title>
<p>6–10<bold> </bold>weeks old female C57BL/6 mice were purchased from Harlan Laboratories, after transfer mice were housed under specific pathogen free conditions in isolated ventilated cages. Animal experiments were reviewed and approved by an appropriate institutional review committee (Genehmigung H2/05 Regierungspräsidium Tübingen).</p>
</sec><sec id="s2b">
<title>Cultivation of <italic>B. adolescentis</italic> and Oral <italic>Yersinia</italic> Infection of Mice</title>
<p>For feeding experiments, <italic>Bifidobacterium adolescentis</italic> Reuter 1963 (ATCC 15705) was anaerobically incubated in soy broth containing beef liver at 37°C for 48<bold> </bold>h, then transferred into <italic>Bifidobacteria</italic> medium (formula according to M58-medium Leibniz Institute <italic>DSMZ-German Collection of Microorgansims and Cell Cultures</italic>) and cultivated under same conditions for additional 48<bold> </bold>h. Bacteria were twice washed in phosphate buffered saline (PBS) (PAA) and thereafter resuspended in aseptic drinking water. 48<bold> </bold>h prior to <italic>B. adolescentis</italic> feeding mice obtained drinking water containing streptomycin (20<bold> </bold>g/l Sigma). Mice were intragastrically infected with 5×10<sup>8</sup> plasmid harboring <italic>Y. enterocolitica</italic> WA-314 serotype O8 <xref ref-type="bibr" rid="pone.0071338-Autenrieth1">[34]</xref> as previously described <xref ref-type="bibr" rid="pone.0071338-Frick2">[33]</xref>. Body weight development of mice was monitored daily, four days post infection mice were sacrificed by carbon dioxide asphyxiation, and subsequently the complete intestine, Peyer's patches, and the spleen were removed.</p>
</sec><sec id="s2c">
<title>Antibiotic Treatment</title>
<p>Prior to <italic>B</italic>. <italic>adolescentis</italic> feeding, streptomycin containing drinking water (20<bold> </bold>g/l Sigma) was administered to mice for 48<bold> </bold>h in order to facilitate efficient <italic>B. adolescentis</italic> colonization. For <italic>B. adolescentis</italic> depletion experiments, mice received vancomycin (1<bold> </bold>g/l Hexal) and metronidazole (1<bold> </bold>g/l Sigma) containing drinking water for 48<bold> </bold>h.</p>
</sec><sec id="s2d">
<title>Determination of Colony Forming Units (CFU) of <italic>Yersinia</italic></title>
<p>Fecal samples, Peyer's patches, and spleens were scaled. Tissue samples were homogenized by extruding through 40 µm cell strainer (BD Falcon). After, complete samples were resuspended in aseptic PBS, serial diluted until a factor of 10<sup>−4</sup>, plated on CIN plates (Oxoid), and incubated for 48<bold> </bold>h at 27°C. CFU were calculated per gram samples. The detection limit of CFU of Yersinia was 10.</p>
</sec><sec id="s2e">
<title>Isolation of Lamina Propria and Intraepithelial Leukocytes</title>
<p>After removal of the complete intestine, Peyer's patches were abscised, the gut was opened longitudinally, and flushed thoroughly with phosphate buffered saline (Gibco) containing fetal calf serum (1 w/v; Sigma) (PBS/FCS). Intestinal epithelial cells were separated from the lamina propria by incubation in 1<bold> </bold>mM dithiothreitol (DTT; AppliChem) and 1<bold> </bold>mM ethylenediaminetetraacetic acid (EDTA) containing PBS under slow rotations. The soluble epithelial fraction was washed in PBS/FCS. Remaining intestinal tissue was washed in PBS/FCS, cut thoroughly, subsequently transferred into digestion solution (VLE RPMI 1640, Biochrom; 200 U/ml collagenase, Sigma; 5 U/ml DNase, Roche; 50 µM β-mercaptoethanol, AppliChem; 5% FCS, Sigma; 2<bold> </bold>mM glutamine, 2500 U/ml penicillin, 2000 µg/ml streptomycin, GIBCO) and incubated for 60<bold> </bold>min under slow rotations. Lamina propria – and epithelial cell suspensions were centrifuged, resuspended in 40% Easycoll (Biochrom) dilution, cautiously layered on 70% Easycoll dilution, and then centrifuged. Leukocytes were extracted from the interlayer and washed.</p>
</sec><sec id="s2f">
<title>Flow Cytometry Analysis of Lamina Propria and Intraepithelial Leukocytes</title>
<p>Isolated lamina propria (lp) and intraepithelial (ie) leukocytes were incubated in FC Receptor Block (Fcγ III/II receptor; clone 2.4G2). Surface markers were stained with antibody concentrations of 1 µl per 1×10<sup>6</sup> cells for 25<bold> </bold>min at 4°C and subsequently washed in PBS/FCS. Applied antibodies were Fluorescein-isothiocyanate (FITC) labeled anti-mouse CD3ε clone 145-2C11, anti-mouse CD19 clone 1D3, anti-mouse CD49b/Pan-NK clone DX5, peridinin-chlorophyll-protein complex (PerCP) labeled anti-mouse CD4 clone RM4-5, allophycocyanin (APC) labeled anti-mouse CD11b clone M1/70, CD45R/B220 clone RA3-6B2, and biotinylated anti-mouse CD11c clone HL3 (BD Bioscience), and phycoerythrin (PE) labeled anti-mouse PDCA-1 clone JF05-1C2.4.1 (Miltenyi Biotec). Specimens containing biotinylated antibodies were thereafter incubated with 1 µl of second step fluorescence conjugate (Streptavidin-PercP; BD Bioscience) for 15<bold> </bold>min at 4°C. Next cells were washed in PBS/FCS and then resuspended in PBS/FCS containing 1.5% paraformaldehyde. For intracellular staining cells were incubated in Cytofix/Cytoperm™ (BD Bioscience) for 20<bold> </bold>min at 4cC then washed in permeabilizing wash buffer (PWB)(PBS, 0.1% saponin (Sigma) and 3% FCS). Thereafter permeabilized cells were stained with 0.5 µl PE labeled anti-mouse FoxP3 clone FJK-16s antibody per 1×10<sup>6</sup> cells for 20<bold> </bold>min at 4°C in PWB. Afterwards cells were first washed in PWB, then in PBS/FCS, and finally resuspended in PBS/FCS containing 1.5% paraformaldehyde. Specimens were measured on a FACSCalibur<sup>TM</sup> or LSRFortessa (BD Bioscience) using BD CellQuest Pro™ or BD FACSDIVA™ software, respectively. Data were analyzed with WinMDI Software Version 2.8 (Joe Trotter) or FlowJo 7.6.4 (TreeStar Inc.). Forward and Side Scatter were used to exclude dead cells, cell debris and cell aggregates of analysis. DCs were analyzed by electronically gating on Lin<sup>−</sup> (CD3ε, CD19, DX5) negative and CD11c-positive (CD11c<sup>+</sup>) cells, as indicated in respective figures. For analyses of FoxP3 expression lamina propria leukocytes were gated on CD3ε and CD4-expressing T cells, as indicated.</p>
</sec><sec id="s2g">
<title>Plasmacytoid Dendritic Cell Depletion</title>
<p>Mice were <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected as earlier described. In addition, mice were 1.5<bold> </bold>days prior to and 0.5<bold> </bold>days post <italic>Yersinia</italic> application intravenously injected with 150 µg of functional grade pure anti-mouse PDCA-1 antibody clone JF05-1C2.4.1 (Miltenyi Biotec) or functional grade purified Rat IgG2b isotype control (eBioscience).</p>
</sec><sec id="s2h">
<title>Statistics</title>
<p>Statistical significances were calculated using unpaired t-test, when variances were statistically significantly different unpaired t-test with Welch's correction was used instead. For experiments with more than two investigated groups statistical significances were calculated using One-way analysis of variance followed by Tukey's Multiple Comparison Test. P values smaller than 0.05 were considered significant.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>The <italic>Bifidobacterium adolescentis</italic>-Mediated Protection from <italic>Yersinia enterocolitica</italic> Infection is Associated with an Increased Proportion of PDCA-1-Positive pDCs</title>
<p>First we analyzed the effect of <italic>B. adolescentis</italic> feeding on the intestinal mucosal immune system, in particular on the composition of intraepithelial (ie) DC and the lamina propria (lp) DC subpopulations and the course of <italic>Yersinia enterocolitica</italic> infection. Therefore female C57BL/6 mice were fed with (i) PBS as mock control (M), (ii) viable <italic>B. adolescentis</italic> (B), (iii) infected with 5×10<sup>8</sup> CFU <italic>Yersinia enterocolitica</italic> (Y) or (iv) fed with <italic>B. adolescentis</italic> and subsequently infected with <italic>Yersinia enterocolitica</italic> (BY).</p>
<p>BY mice (3.2%±7%) were significantly protected in terms of weight loss as compared to Y mice (−9.3%±3.4%; p = 0.0223) (<xref ref-type="fig" rid="pone-0071338-g001"><bold>Fig. 1A</bold></xref>). Determination of CFU of <italic>Yersinia</italic> in the Peyer's patches revealed no differences between BY (log<sub>10</sub> 3.7±1.8) and Y (log<sub>10</sub> 3.4±1.8) mice (<xref ref-type="fig" rid="pone-0071338-g001"><bold>Fig. 1B</bold></xref>). However, the BY mice were protected from dissemination of <italic>Yersinia</italic> during infection as indicated by the significantly reduced CFU of <italic>Yersinia</italic> in the spleens of <italic>B. adolescentis</italic> fed <italic>Y. enterocolitica</italic> infected mice (log<sub>10</sub> 0.5±1.6) when compared to Y mice (log<sub>10</sub> 2.5±2.5; p = 0.0036) (<xref ref-type="fig" rid="pone-0071338-g001"><bold>Fig. 1C</bold></xref>). We were able to exclude that feeding of <italic>B. adolescentis</italic> reduced the number of intestinal enteropathogenic <italic>Yersinia</italic> in the BY mice, since BY (log<sub>10</sub> 6.5±0.9) and Y mice (log<sub>10</sub> 6.2±0.8) harbored comparable counts of <italic>Yersinia</italic> in the intestine (<xref ref-type="fig" rid="pone-0071338-g001"><bold>Fig. 1D</bold></xref>).</p>
<fig id="pone-0071338-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.g001</object-id><label>Figure 1</label><caption>
<title><italic>B. adolescentis</italic> Feeding Prevents From Weight Loss and Dissemination of <italic>Yersinia</italic> to the Spleen.</title>
<p>(<bold>A</bold>) Graph represents percent modulation of initial body weight over four days of <italic>Yersinia</italic> infected mice (Y, black line and squares) and <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY, gray line and diamonds). Colony forming units (CFU) of <italic>Yersinia</italic> in log<sub>10</sub> per gram Peyer's patches (PP) (<bold>B</bold>), spleen (<bold>C</bold>), or feces (<bold>D</bold>) of <italic>Yersinia</italic> infected mice (Y) and <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY). Data represent mean and SEM of at least 8 mice.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.g001" position="float" xlink:type="simple"/></fig>
<p>These results are in line with previous results of our group demonstrating protective effects of <italic>B. adolescentis</italic> in both, inflammatory as well as infectious intestinal diseases <xref ref-type="bibr" rid="pone.0071338-Frick2">[33]</xref>.</p>
<p>Analysis of ieDC frequency in the intestine of differently treated mice, exhibited a significant increase in the percentage of ieDCs in Y mice (1.8%±0.3%) as compared to remaining groups (M (0.9%±0.1%) p&lt;0.001, B (0.7%±0.2%) p&lt;0.001, BY (0.6%±0.1%) p&lt;0.001) (<xref ref-type="fig" rid="pone-0071338-g002"><bold>Fig. 2A</bold></xref><bold>, </bold><xref ref-type="table" rid="pone-0071338-t001"><bold>Table 1</bold></xref>). This finding was confirmed by total numbers of dendritic cells which were present in different groups (M (1.9×10<sup>4</sup>±1.3×10<sup>4</sup>) p&lt;0.001, B (3.0×10<sup>4</sup>±0.8×10<sup>4</sup>) p&lt;0.01, Y (5.7×10<sup>4</sup>±0.9×10<sup>4</sup>), BY (1.9×10<sup>4</sup>±1.3×10<sup>4</sup>) p&lt;0.001) (<xref ref-type="table" rid="pone-0071338-t001"><bold>Table 1</bold></xref>).</p>
<fig id="pone-0071338-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.g002</object-id><label>Figure 2</label><caption>
<title>B. adolescentis Feeding Results in Increased Plasmacytoid DC Frequency.</title>
<p>(<bold>A</bold>) Intraepithelial dendritic cells (ieDC) were analyzed by gating on linage negative (CD3ε, CD19, DX5) and CD11c-positive cells, as demonstrated in exemplarily depicted dot plots. Graph represents mean percentage ± SEM of CD11c<sup>+</sup> intraepithelial leukocytes of untreated mock (M, dark gray bar), <italic>B. adolescentis</italic> fed (B, white bar), <italic>Yersinia</italic> infected (Y, black bar), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY, gray bar). (<bold>B</bold>) Histograms represent mean percentage ± SD of CD11b-expressing conventional ieDCs (solid black line) and respective fluorescence minus one control (gray filled histogram). (<bold>C</bold>) Dot plots indicate mean percentage ± SD of B220 and PDCA-1-expressing plasmacytoid ieDCs of mock (M), <italic>B. adolescentis</italic> fed (B), <italic>Yersinia</italic> infected (Y), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY). Data represent five mice per group.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0071338-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.t001</object-id><label>Table 1</label><caption>
<title>Cell Counts of Total Intraepithelial DCs, Conventional, and Plasmacytoid DCs.</title>
</caption><alternatives><graphic id="pone-0071338-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Colonization</td>
<td align="left" rowspan="1" colspan="1">CD11c<sup>+</sup> cells</td>
<td align="left" rowspan="1" colspan="1">Conventional DC</td>
<td align="left" rowspan="1" colspan="1">Plasmacytoid DC</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>4</sup></td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>M</bold></td>
<td align="left" rowspan="1" colspan="1">1.9±1.3</td>
<td align="left" rowspan="1" colspan="1">6.1±5.6</td>
<td align="left" rowspan="1" colspan="1">1.7±0.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>B</bold></td>
<td align="left" rowspan="1" colspan="1">3.0±0.8</td>
<td align="left" rowspan="1" colspan="1">5.9±1.2</td>
<td align="left" rowspan="1" colspan="1">7.7±2.4<sup>c</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Y</bold></td>
<td align="left" rowspan="1" colspan="1">5.7±0.9<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">19,9±10<sup>b</sup></td>
<td align="left" rowspan="1" colspan="1">4.8±2.7</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>BY</bold></td>
<td align="left" rowspan="1" colspan="1">1.9±1.3</td>
<td align="left" rowspan="1" colspan="1">4.4±3.5</td>
<td align="left" rowspan="1" colspan="1">3.5±3</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>Numbers indicate mean cell counts ± SD of untreated mock (M), <italic>B. adolescentis</italic> fed (B), <italic>Yersinia</italic> infected (Y), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY) mice. <sup>a</sup> M vs. Y p&lt;0.001, B vs. Y p&lt;0.01, BY vs. Y p&lt;0.001; <sup>b</sup> M vs. Y p&lt;0.05, B vs. Y p&lt;0.05, BY vs. Y p&lt;0.01; <sup>c</sup> Mock vs. B p&lt;0.01, and B vs. BY p&lt;0.05. Data represent five mice per group.</p></fn></table-wrap-foot></table-wrap>
<p>Next the ieDC subset composition of mice with or without <italic>B. adolescentis</italic> feeding and with or without <italic>Yersinia</italic> infection, respectively, was investigated. Since great parts of intestinal conventional (c) DC, positive for either CX<sub>3</sub>CR1 or CD103, express CD11b <xref ref-type="bibr" rid="pone.0071338-Bogunovic1">[26]</xref> we used for the sake of convenience this marker to determine cDC. Results demonstrated that feeding of <italic>B. adolescentis</italic> led to a significantly reduced percentage of CD11c<sup>+</sup>CD11b<sup>+</sup> ieDCs in both B and BY mice (M (31.9%±11.2%) vs. B (19.3%±5.8%) p&lt;0.05, Y (34.7%±2.9%) vs. BY (22.7±2.1%) p&lt;0.05, B vs. Y p&lt;0.01).</p>
<p>No significant differences in the percentage frequency of CD11c<sup>+</sup>CD11b<sup>+</sup> ieDC of Y mice were observed as compared to M mice (<xref ref-type="fig" rid="pone-0071338-g002"><bold>Fig. 2B</bold></xref>). However, analysis of total numbers indicated a significant increase of CD11c<sup>+</sup>CD11b<sup>+</sup> ieDCs only in Y mice (Y (19.9×10<sup>3</sup>±10×10<sup>3</sup>) as compared to all other groups (M (6.1×10<sup>3</sup>±5.6×10<sup>3</sup>) p&lt;0.05, B (5.9×10<sup>3</sup>±1.2×10<sup>3</sup>) p&lt;0.05, BY (4.4×10<sup>3</sup>±3.5×10<sup>3</sup>) p&lt;0.01) (<xref ref-type="table" rid="pone-0071338-t001"><bold>Table 1</bold></xref>). The differences between absolute numbers of CD11c<sup>+</sup>CD11b<sup>+</sup> ieDCs between M mice and Y mice might be caused by an increased influx of CD11c<sup>+</sup> leukocytes to the <italic>Yersinia</italic> infected intestine (<xref ref-type="table" rid="pone-0071338-t001"><bold>Table 1</bold></xref>).</p>
<p>Analysis concentrating on the percentage of CD11c<sup>+</sup>B220<sup>+</sup>PDCA-1<sup>+</sup>-expressing plasmacytoid (p)DCs demonstrated, however, that feeding of <italic>B. adolescentis</italic> resulted in a significantly increased percentage of pDCs in both B mice and BY mice (M (9.2%±1.2%) vs. B (25.7%±4.8%) p&lt;0.001, Y (8.3%±2.5%) vs. BY (18.2%±8.4%) p&lt;0.05, B vs. Y p&lt;0.001) (<xref ref-type="fig" rid="pone-0071338-g002"><bold>Fig. 2B</bold></xref>). The total number of pDCs was significantly increased in B mice (7.7×10<sup>3</sup>±2.4×10<sup>3</sup>) but not in the other groups (M (1.7×10<sup>3</sup>±0.5×10<sup>3</sup>) p&lt;0.01, Y (4.8×10<sup>3</sup>±2.7×10<sup>3</sup>), BY (3.5×10<sup>3</sup>±3×10<sup>3</sup>) p&lt;0.05).</p>
<p>The percentage frequency of pDC in BY mice might lead to the conclusion that BY mice need to have higher absolute cell counts as Y mice do. However, due to the fact that Y mice have in general a high absolute number of dendritic cells these mice even have with a low percentage frequency of pDC a high absolute frequency. Nevertheless, in Y mice the ratio between pDC and cDC is shifted in favor of cDC whereas in BY mice it is more balanced (<xref ref-type="fig" rid="pone-0071338-g002">Fig. 2</xref>, <xref ref-type="table" rid="pone-0071338-t001"><bold>Table 1</bold></xref>).</p>
<p>The analysis of the lpDCs gave comparable results: a significant decrease of CD11c<sup>+</sup>CD11b<sup>+</sup> lpDCs (M (70%±5.1%) vs. B (58.6%±8.2%) p&lt;0.05, Y (70.7%±3.8%) vs. BY (57.7%±9.3%) p&lt;0.05, M vs. BY p&lt;0.05, B vs. Y p&lt;0.05) and a significant increase in CD11c<sup>int</sup>B220<sup>+</sup> and CD11c<sup>int</sup>PDCA-1<sup>+</sup> plasmacytoid (p) DCs in <italic>B. adolescentis</italic> fed mice regardless of additional infection with <italic>Yersinia</italic> or not (CD11c<sup>int</sup>B220<sup>+</sup>: M (6.8%±1.3%) vs. B (16.8%±1.4%) p&lt;0.001, Y (6.7%±2%) vs. BY (17.2%±3.2%) p&lt;0.001, M vs. BY p&lt;0.001, B vs. Y p&lt;0.001; CD11c<sup>int</sup>PDCA-1<sup>+</sup>: M (2.9%±0.7%) vs. B (9.3%±1.2%) p&lt;0.001, Y (2.9%±1.5%) vs. BY (6.7%±1.4%) p&lt;0.001, M vs. BY p&lt;0.001, B vs. Y p&lt;0.001, B vs. BY p&lt;0.001). (<bold><xref ref-type="supplementary-material" rid="pone.0071338.s001">Fig. S1</xref>, <xref ref-type="supplementary-material" rid="pone.0071338.s002">Table S1</xref>, <xref ref-type="supplementary-material" rid="pone.0071338.s002">Table S2</xref></bold>). To exclude that the enhanced frequency of pDCs in B and BY mice was due to streptomycin treatment prior to <italic>B. adolescentis</italic> administration C57BL/6 mice were treated with streptomycin (S) only and the frequency of intraepithelial pDCs was analyzed. Application of streptomycin did not result in an increase frequency of pDCs (M (8.1%±2.9%, 1.1×10<sup>4</sup>±0.6×10<sup>4</sup>); S (9.5%±3.6%, 1.2×10<sup>4</sup>±0.5×10<sup>4</sup>), therefore we can exclude the influence of streptomycin treatment or streptomycin caused alterations of the intestinal microbiota on the recruitment or onsite development of pDCs (<xref ref-type="fig" rid="pone-0071338-g003"><bold>Fig. 3A</bold></xref><bold>,</bold> <xref ref-type="table" rid="pone-0071338-t002"><bold>Table 2</bold></xref>). In order to demonstrate that the increased frequency of intraepithelial pDCs in B and BY mice is a result of <italic>B. adolescentis</italic> feeding, mice were either fed with <italic>B. adolescentis</italic> for 6<bold> </bold>days or not and subsequently treated with vancomycin and metronidazole for 2<bold> </bold>days. After 5<bold> </bold>weeks the frequency of intraepithelial pDCs was determined. The antibiotics-induced reduction of <italic>B. adolescentis</italic> in the intestine resulted in comparable numbers of pDCs in antibiotic treated mock (28.4%±10.9%, 16.8×10<sup>3</sup>±1.3×10<sup>3</sup>) as well as <italic>B. adolescentis</italic> fed and antibiotic treated mice (25.1%±7%, 9.3×10<sup>3</sup>±3.1×10<sup>3</sup>). However, it remains elusive whether this is a direct effect of <italic>B. adolescentis</italic> or a secondary effect on the intestinal microbiota (<xref ref-type="fig" rid="pone-0071338-g004"><bold>Fig. 4A</bold></xref><bold>,</bold> <xref ref-type="table" rid="pone-0071338-t003"><bold>Table 3</bold></xref>).</p>
<fig id="pone-0071338-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.g003</object-id><label>Figure 3</label><caption>
<title>Streptomycin Treatment does Neither Induce Intraepithelial pDCs nor Lamina Propria T<sub>reg</sub> Cells.</title>
<p>Mean percentage ± SD of (<bold>A</bold>) intraepithelial B220<sup>+</sup>PDCA-1<sup>+</sup> plasmacytoid DCs and (<bold>B</bold>) lamina propria FoxP3-expressing regulatory T cells (solid black line) and fluorescence minus one control (gray filled histograms) of untreated mock (M) and streptomycin (S) treated mice. Intraepithelial plasmacytoid cells and lamina propria CD4<sup>+</sup> T cells were gated as indicated in Fig. 2 and Fig. 5, respectively. Data represent at least four mice per group.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.g003" position="float" xlink:type="simple"/></fig><fig id="pone-0071338-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.g004</object-id><label>Figure 4</label><caption>
<title><italic>B. adolescentis</italic> Depletion Results in Comparable Frequencies of Intraepithelial pDCs and Lamina Propria T<sub>reg</sub> Cells.</title>
<p>Mean percentage ± SD of (<bold>A</bold>) intraepithelial B220<sup>+</sup>PDCA-1<sup>+</sup> plasmacytoid DCs and (<bold>B</bold>) lamina propria FoxP3-expressing regulatory T cells (solid black line) and fluorescence minus one control (gray filled histograms) of vancomycin and metronidazole treated mock (M+ antibiotics) and <italic>B. adolescentis</italic> (B+ antibiotics) (B) fed mice. Intraepithelial plasmacytoid cells and lamina propria CD4+T cells were gated as indicated in Fig. 2 and Fig. 5, respectively. Data represent five mice per group.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.g004" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0071338-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.t002</object-id><label>Table 2</label><caption>
<title>Cell Counts of Intraepithelial Plasmacytoid DCs, and Lamina Propria FoxP3<sup>+</sup> T<sub>reg</sub> Cells.</title>
</caption><alternatives><graphic id="pone-0071338-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Treatment</td>
<td align="left" rowspan="1" colspan="1">Plasmacytoid DC</td>
<td align="left" rowspan="1" colspan="1">CD4<sup>+</sup> FoxP3<sup>+</sup>cells</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>4</sup></td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>1</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>M</bold></td>
<td align="left" rowspan="1" colspan="1">1.1±0.6</td>
<td align="left" rowspan="1" colspan="1">8.7±6.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>S</bold></td>
<td align="left" rowspan="1" colspan="1">1.2±0.5</td>
<td align="left" rowspan="1" colspan="1">0.7±0.1</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt102"><label/><p>Numbers indicate mean cell counts±SD of untreated mock (M) and streptomycin (S) treated mice. Data represent at least four mice per group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0071338-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.t003</object-id><label>Table 3</label><caption>
<title>Cell Counts of Intraepithelial Plasmacytoid DCs, and Lamina Propria FoxP3<sup>+</sup> T<sub>reg</sub> Cells.</title>
</caption><alternatives><graphic id="pone-0071338-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Treatment</td>
<td align="left" rowspan="1" colspan="1">Plasmacytoid DC</td>
<td align="left" rowspan="1" colspan="1">CD4<sup>+</sup> FoxP3<sup>+</sup>cells</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>M + antibiotics</bold></td>
<td align="left" rowspan="1" colspan="1">16.8±1.3</td>
<td align="left" rowspan="1" colspan="1">3.4±2.5<sup>a</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>B + antibiotics</bold></td>
<td align="left" rowspan="1" colspan="1">9.3±3.1</td>
<td align="left" rowspan="1" colspan="1">0.3±0.3</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>Numbers indicate mean cell counts±SD of vancomycin and metronidazole treated mock (M)and <italic>B. adolescentis</italic> (B) fed mice. Data represent five mice per group. <sup>a</sup> p = 0.00494.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b">
<title><italic>B. adolescentis</italic>-Mediated Protection is Associated with an Increase in FoxP3<sup>+</sup> Regulatory T Cells</title>
<p>Plasmacytoid DCs are described to induce both protective adaptive immunity as well as immune tolerance, depending on their localization and state of activation <xref ref-type="bibr" rid="pone.0071338-Schlitzer1">[22]</xref>. Moreover, this subset is associated with the induction of FoxP3<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>-expressing regulatory T cells (T<sub>reg</sub> cells) <xref ref-type="bibr" rid="pone.0071338-Hadeiba1">[35]</xref> therefore we next analyzed the frequency of CD3ε<sup>+</sup>CD4<sup>+</sup> cells and of FoxP3<sup>+</sup>CD4<sup>+</sup> T<sub>reg</sub> cells.</p>
<p>Independent of treatment, mice exhibited no differences in the percentage and absolute number of CD4<sup>+</sup> T cells (M (3.5%±0.3%, 1.3×10<sup>5</sup>±0.7×10<sup>5</sup>), B (3.1%±0.1%, 1×10<sup>5</sup>±0.4×10<sup>5</sup>), Y (4.4%±1.5%, 0.9×10<sup>5</sup>±0.5×10<sup>5</sup>), BY (3.9%±1.5%, 0.9×10<sup>5</sup>±0.4×10<sup>5</sup>) (<xref ref-type="fig" rid="pone-0071338-g005"><bold>Fig. 5A</bold></xref><bold>, </bold><xref ref-type="table" rid="pone-0071338-t004"><bold>Table 4</bold></xref>). In contrast, we observed significant differences in the frequency of FoxP3<sup>+</sup>CD4<sup>+</sup>T<sub>reg</sub> cells. Feeding of <italic>B. adolescentis</italic> resulted in a significant increase in FoxP3<sup>+</sup>CD4<sup>+</sup>T<sub>reg</sub> cell percentages (M (1.7%±0.8%) vs. B (4.8%±1) p&lt;0.05, Y (0.8%±0.3%) vs. BY (4.8%±2.5%) p&lt;0.001, M vs. BY P&lt;0.05, B vs. Y p&lt;0.001) and absolute numbers (M (2.2×10<sup>3</sup>±0.9×10<sup>3</sup>), B (4.9×10<sup>3</sup>±1.3×10<sup>3</sup>) p&lt;0.01, Y (0.7×10<sup>3</sup>±0.4×10<sup>3</sup>) vs. BY (4.2×10<sup>3</sup>±1.3×10<sup>3</sup>) p&lt;0.001, M vs. BY p&lt;0.05, B vs. Y p&lt;0.001) in mice. Furthermore, not even additional infection with <italic>Yersinia</italic> influenced this fact (<xref ref-type="fig" rid="pone-0071338-g005"><bold>Fig. 5B</bold></xref><bold>, </bold><xref ref-type="table" rid="pone-0071338-t004"><bold>Table 4</bold></xref>). In line with the control experiments for pDCs, treatment of mice with streptomycin (S) had no impact on the frequency of FoxP3-positive T cells (M (1.2%±1.1%, 8.7×10<sup>1</sup>±6.5×10<sup>1</sup>) S (0.5%±0.9%, 0.7×10<sup>1</sup>±0.1×10<sup>1</sup>) (<xref ref-type="fig" rid="pone-0071338-g003"><bold>Fig. 3B</bold></xref><bold>, </bold><xref ref-type="table" rid="pone-0071338-t002"><bold>Table 2</bold></xref>). However, depletion of <italic>B. adolescentis</italic> resulted in significantly different percentage and cell count frequency of T<sub>reg</sub> cells (M +antibiotics (1.5%±0.6%) vs. B + antibiotics (0.5%±0.6%) p = 0.00361; M +antibiotics (3.4×10<sup>3</sup>±2.5×10<sup>3</sup>) vs. B + antibiotics (0.3×10<sup>3</sup>±0.3×10<sup>3</sup>) p = 0.0494) (<xref ref-type="fig" rid="pone-0071338-g004"><bold>Fig. 4B</bold></xref><bold>, </bold><xref ref-type="table" rid="pone-0071338-t003"><bold>Table 3</bold></xref>).</p>
<fig id="pone-0071338-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.g005</object-id><label>Figure 5</label><caption>
<title><italic>B. adolescentis</italic> feeding increases Frequencies of Lamina Propria T<sub>reg</sub> Cells Independent from State of Inflammation.</title>
<p>Mean percentage ± SD of lamina propria (A) CD3ε<sup>+</sup>CD4<sup>+</sup> T cells and (B) FoxP3-expressing regulatory CD3ε<sup>+</sup>CD4<sup>+</sup> T cells (solid black line) and fluorescence minus one control (gray filled histograms) of mock (M), <italic>B. adolescentis</italic> fed (B), <italic>Yersinia</italic> infected (Y), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY) mice. Cells were gated as indicated. Data represent at least five mice per group.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.g005" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0071338-t004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.t004</object-id><label>Table 4</label><caption>
<title>Counts of Lamina Propria CD4<sup>+</sup> T cells and FoxP3<sup>+</sup> Regulatory T Cells.</title>
</caption><alternatives><graphic id="pone-0071338-t004-4" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.t004" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Colonization</td>
<td align="left" rowspan="1" colspan="1">CD3<sup>+</sup>CD4<sup>+</sup> cells</td>
<td align="left" rowspan="1" colspan="1">CD4<sup>+</sup> FoxP3<sup>+</sup>cells</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>5</sup></td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>M</bold></td>
<td align="left" rowspan="1" colspan="1">1.3±0.7</td>
<td align="left" rowspan="1" colspan="1">2.2±0.9<sup>a</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>B</bold></td>
<td align="left" rowspan="1" colspan="1">1±0.4</td>
<td align="left" rowspan="1" colspan="1">4.9±1.3</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Y</bold></td>
<td align="left" rowspan="1" colspan="1">0.9±0.5</td>
<td align="left" rowspan="1" colspan="1">0.7±0.4<sup>b</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>BY</bold></td>
<td align="left" rowspan="1" colspan="1">0.9±0.4</td>
<td align="left" rowspan="1" colspan="1">4.2±1.3</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt104"><label/><p>Numbers indicate mean cell counts ± SD of untreated mock (M), <italic>B. adolescentis</italic> fed (B), <italic>Yersinia</italic> infected (Y), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY) mice. <sup>a</sup> M vs. B p&lt;0.01, M vs. BY p&lt;0.05, <sup>b</sup> B vs. Y p&lt;0.001, BY vs. Y p&lt;0.001. Data represent at least five mice per group.</p></fn></table-wrap-foot></table-wrap>
<p>From the above results, we conclude that feeding of <italic>B. adolescentis</italic> might promote development of T<sub>reg</sub> cells.</p>
</sec><sec id="s3c">
<title>Plasmacytoid DCs are Crucial for Inhibition of <italic>Y. enterocolitica</italic> Dissemination</title>
<p>In order to examine the inhibitory function of <italic>B. adolescentis</italic>-induced CD11c<sup>int</sup>B220<sup>+</sup>PDCA-1<sup>+</sup> plasmacytoid (p) DCs on <italic>Y. enterocolitica</italic> dissemination we performed pDC depletion experiments. Therefore we injected <italic>B. adolescentis</italic> fed C57BL/6 mice with anti-mouse PDCA-1 antibody or respective isotype control prior to and during <italic>Yersinia</italic> infection.</p>
<p>Successful depletion of pDCs by anti-mouse PDCA-1 antibody injections was verified using flow cytometry analyses. In order to determine pDCs, lpDCs were stained with anti-mouse B220 antibody. Injections of the isotype control had no effect on the proportion of B220<sup>+</sup> pDCs (13.1%±1.2%, 1.1×10<sup>3</sup>±0.5×10<sup>3</sup>) (<xref ref-type="fig" rid="pone-0071338-g006"><bold>Fig. 6A</bold></xref><bold>,</bold> <xref ref-type="table" rid="pone-0071338-t005"><bold>Table 5</bold></xref>) and resulted in same levels as in untreated <italic>B. adolescentis</italic> fed mice (16.8%±1.4%) <bold><xref ref-type="supplementary-material" rid="pone.0071338.s001">Fig. S1</xref></bold>). <italic>B. adolescentis</italic> fed pDC depleted mice, however, showed a significantly reduced frequency of B220<sup>+</sup> pDCs (8.3%±2.5% p = 0.0134, 0.5×10<sup>3</sup>±0.2×10<sup>3</sup>) (<xref ref-type="fig" rid="pone-0071338-g006"><bold>Fig. 6A</bold></xref><bold>,</bold> <xref ref-type="table" rid="pone-0071338-t005"><bold>Table 5</bold></xref>), which was comparable to untreated mock mice (6.8%±1.3%) (<bold><xref ref-type="supplementary-material" rid="pone.0071338.s001">Fig. S1</xref></bold>). Interestingly, we demonstrated that only injections of the anti-mouse PDCA-1 antibody abrogated <italic>B. adolescentis</italic>-mediated prevention of <italic>Yersinia</italic> dissemination whereas the isotype control failed. This fact is indicated by a significantly increased splenic <italic>Yersinia</italic> load of anti-mouse PDCA-1 antibody injected <italic>B. adolescentis</italic> fed mice (CFU log<sub>10</sub> 6.8±2.2) when compared to isotype control injected <italic>B. adolescentis</italic> fed mice (CFU log<sub>10</sub> 2.4±2.4, p = 0.0373) (<xref ref-type="fig" rid="pone-0071338-g006"><bold>Fig. 6B</bold></xref>).</p>
<fig id="pone-0071338-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.g006</object-id><label>Figure 6</label><caption>
<title>Depletion of pDCs Abrogates <italic>B. adolescentis</italic>-Mediated Prevention of <italic>Yersinia</italic> Dissemination.</title>
<p>Lamina propria dendritic cells (lpDC) were analyzed by gating on linage negative (CD3ε, CD19, DX5) and CD11c-intermediate cells, as demonstrated in exemplarily depicted dot plots (<bold>A</bold>) Mean percentage ± SD of B220<sup>+</sup> lamina propria plasmacytoid DCs (solid black line) and fluorescence minus one control (gray filled histograms) (<bold>B</bold>) and splenic CFU of <italic>Yersinia</italic> in log<sub>10</sub> per gram of <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice, either injected with anti-mouse PDCA-1 (n = 5) or respective isotype control (n = 3).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.g006" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0071338-t005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0071338.t005</object-id><label>Table 5</label><caption>
<title>Percentages and Cell Counts of Lamina Propria CD11c<sup>int</sup> DCs and B220<sup>+</sup> Plasmacytoid DCs.</title>
</caption><alternatives><graphic id="pone-0071338-t005-5" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0071338.t005" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Injected antibody</td>
<td colspan="2" align="left" rowspan="1">CD11c<sup>int</sup>cells</td>
<td align="left" rowspan="1" colspan="1">B220<sup>+</sup>cells</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"/>
<td align="left" rowspan="1" colspan="1">% leukocytes</td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
<td align="left" rowspan="1" colspan="1">cell count ×10<sup>3</sup></td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Isotype</bold></td>
<td align="left" rowspan="1" colspan="1">1.1±0.1<sup>a</sup></td>
<td align="left" rowspan="1" colspan="1">8.1±3.7</td>
<td align="left" rowspan="1" colspan="1">1.1±0.5</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>α-PDCA-1</bold></td>
<td align="left" rowspan="1" colspan="1">0.6±0.2</td>
<td align="left" rowspan="1" colspan="1">6.2±2.7</td>
<td align="left" rowspan="1" colspan="1">0.5±0.2</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt105"><label/><p>Numbers indicate mean percentages ± SD and mean cell counts ± SD of <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice, either injected with anti-mouse PDCA-1 (n = 5) or respective isotype control (n = 3). <sup>a</sup> p = 0.0072.</p></fn></table-wrap-foot></table-wrap>
<p>Based on the presented results we hypothesize that feeding of <italic>B. adolescentis</italic> might lead, by a yet unknown mechanism, to recruitment or increased onsite development of pDCs, which might promote development of regulatory T cells. We suggest that this immune response favors intestinal homoeostasis rather than inflammation, strengthens the intestinal barrier and thereby contributes to inhibition of <italic>Yersinia enterocolitica</italic> dissemination.</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>Commensals are thought to modulate the susceptibility of the host towards intestinal infections. We recently showed that commensal <italic>B. adolescentis</italic> protects mice from <italic>Yersinia enterocolitica</italic> infection <xref ref-type="bibr" rid="pone.0071338-Frick2">[33]</xref>. In line with these results the present study demonstrates that <italic>B. adolescentis</italic>-mediated protection is associated with increased frequency of T<sub>reg</sub> cells and pDCs. This DC subset seems to be crucial for protection since depletion of pDCs abrogated protection.</p>
<p>The intestinal microbiota exerts a variety of functions thereby strengthen the host resistance against intestinal infections. The high bacterial density and diversity in the mammalian intestine contributes to the prevention from infections with opportunistic and strict pathogens. This mechanism is known as colonization resistance and disturbances of microbial composition leads to an increased susceptibility to e.g. enteric infections <xref ref-type="bibr" rid="pone.0071338-Sekirov2">[36]</xref> or <italic>Clostridium difficile</italic>. <xref ref-type="bibr" rid="pone.0071338-Lawley1">[37]</xref>. However, in this study colonization resistance seems not to be the underlying mechanism of <italic>B. adolescentis</italic>-mediated protection since <italic>Yersinia</italic> loads in Peyer's patches (PP) and fecal samples were comparable between groups.</p>
<p>In addition, the metabolism of the host depends on the microbiota to degrade otherwise indigestible nutritional carbohydrates which results in the release of short chain fatty acids providing an additional energy source. <xref ref-type="bibr" rid="pone.0071338-Cummings1">[38]</xref>. Metabolic byproducts fulfill additional tasks indicated by the fact that released short chain fatty acids attenuate intestinal inflammation <xref ref-type="bibr" rid="pone.0071338-Maslowski1">[39]</xref> and protect from enteropathogenic infection <xref ref-type="bibr" rid="pone.0071338-Fukuda1">[40]</xref> in mice.</p>
<p>Moreover, commensals are important to maintain and increase the hosts intestinal epithelial barrier function which helps to defend invasive pathogens. In intestinal epithelial cells (IEC) the recognition of commensal components and metabolites can result in the induction of tight junctions <xref ref-type="bibr" rid="pone.0071338-Bansal1">[41]</xref>, <xref ref-type="bibr" rid="pone.0071338-Cario1">[42]</xref>, cell growth <xref ref-type="bibr" rid="pone.0071338-Yan1">[43]</xref>, as well as mucus production <xref ref-type="bibr" rid="pone.0071338-Kim1">[44]</xref>, <xref ref-type="bibr" rid="pone.0071338-Otte1">[45]</xref>. Furthermore, the presence of commensals leads to secretion of antimicrobial compounds by IEC <xref ref-type="bibr" rid="pone.0071338-Wehkamp1">[46]</xref> enhancing the intestinal innate immune response to pathogens <xref ref-type="bibr" rid="pone.0071338-Brandl1">[13]</xref>, <xref ref-type="bibr" rid="pone.0071338-Kinnebrew1">[47]</xref>. In addition to the host, bacteria secrete antimicrobial compounds themselves, termed bacteriocins, able to change the microbial composition <xref ref-type="bibr" rid="pone.0071338-Murphy1">[48]</xref>. The presence of <italic>B. adolescentis</italic> might protect from Yersiniosis owing to an increase in epithelial barrier function either by direct interactions with IEC or by alterations of the microbiota composition.</p>
<p>The host's resistance to pathogens relies on a fully functional gastrointestinal immune system, which develops from an immature state only after microbiota acquisition <xref ref-type="bibr" rid="pone.0071338-Mazmanian1">[49]</xref>. Moreover, the microbiota complexity directly influences intestinal dendritic cell subset composition. A less diverse microbiota resulted in reduced frequency of plasmacytoid dendritic cells in lymphoid tissues <xref ref-type="bibr" rid="pone.0071338-Fujiwara1">[50]</xref> and administration of the probiotic preparation VSL#3 decreased the pDC content in the lamina propria of mice. Our results additionally proof the influence of the microbiota diversity on DC composition since <italic>B. adolescentis</italic> feeding was associated with an increase in pDCs. These findings suggest that bacterial compounds might directly induce on-site development or the recruitment of plasmacytoid DCs into the intestinal compartment. The rise in pDCs might depend on invariant NKT (iNKT) cells since a recent study demonstrated that iNKT cells are responsible for the recruitment of pDCs to the pancreas during lymphocytic choriomeningitis virus infection <xref ref-type="bibr" rid="pone.0071338-Diana1">[51]</xref>. In this study the release of glycolipids by <italic>B. adolescentis</italic> might result in the activation of iNKT cells which in turn may initiate the recruitment of pDCs to the intestine. The crucial function of pDCs is demonstrated by abolished <italic>B. adolescentis</italic>-mediated protection during Yersiniosis after depletion of pDCs. Depending on location the secretion of type I interferons (IFN) by pDCs can differ, since murine splenic pDCs secret high amounts of IFN-α upon TLR9 ligand stimulation whereas pDC of PP don't. In addition, treatment of splenic pDCs with IL-10, prostaglandine E2, and TGF-β, present at mucosal sites, prevents IFN induction, indicating that the mucosal microenvironment might condition pDCs for poor Type I IFN production <xref ref-type="bibr" rid="pone.0071338-Contractor1">[52]</xref>. In contrast, peripheral blood pDCs of IBD patients are impaired to secret IFN-α and simultaneously secret increased amounts of pro-inflammatory cytokines after TLR9 ligand challenge <xref ref-type="bibr" rid="pone.0071338-Baumgart1">[30]</xref>. Moreover, IBD patients exhibit an increased frequency of pDCs in the intestinal mucosa when compared to controls <xref ref-type="bibr" rid="pone.0071338-Baumgart1">[30]</xref>. A rise in pDC frequency may be supposed to attenuate inflammation which might be insufficient owing to reduced IFN-α secretion. In line with this is the fact that type I interferons secreted by DCs ameliorate DSS-induced colonic injury and inflammation in mice <xref ref-type="bibr" rid="pone.0071338-Katakura1">[53]</xref> and that <italic>ifnar<sup>−/−</sup></italic> deficient mice are more susceptible to DSS <xref ref-type="bibr" rid="pone.0071338-Katakura1">[53]</xref>, <xref ref-type="bibr" rid="pone.0071338-McFarland1">[54]</xref>. However, IFN-β seems not to be protective in general since administration of IFN-β producing <italic>Lactobacilli</italic> to mice exacerbates DSS-induced disease <xref ref-type="bibr" rid="pone.0071338-McFarland1">[54]</xref>. In addition, might result the <italic>B. adolescentis</italic>-mediated increase in pDCs in a decreased migration rate of CD103-positive DC to the mesenteric lymph nodes due to a reduced expression of CCR7. Since, in vitro stimulated bone marrow-derived DC exhibited a reduced expression of CCR7 after stimulation with cytokines when IFN-β was present <xref ref-type="bibr" rid="pone.0071338-Yen1">[55]</xref>. CD103-expressing DC were shown to be responsible for the transport of living <italic>Salmonella typhimurium</italic> cells to the mesenteric lymph nodes in a CCR7 dependent manner <xref ref-type="bibr" rid="pone.0071338-Bogunovic1">[26]</xref>. Moreover, a recent publication demonstrated that CD103-positive DC are able to sample, in addition to CX<sub>3</sub>CR1 expressing DC, luminal <italic>Salmonella typhimurium</italic> cells by the production of transepithelial dendrites <xref ref-type="bibr" rid="pone.0071338-Farache1">[56]</xref>. In this study <italic>Y. enterocolitica</italic> might also be transported by CD103-expressing DC to the mesenteric lymph nodes. Therefore <italic>B. adolescentis</italic>-induced pDCs might secret IFN-β which act on CD103-epxressing cells resulting in a lower expression of CCR7 and a decreased migration rate to the mesenteric lymph nodes. This in turn might prevent the transport of <italic>Y. enterocolitica</italic> to the mesenteric lymph nodes.</p>
<p>The potential of pDCs to induce regulatory T (<sub>Treg</sub>) cells was demonstrated for human <xref ref-type="bibr" rid="pone.0071338-Hadeiba1">[35]</xref> and murine cells <xref ref-type="bibr" rid="pone.0071338-Ito1">[57]</xref>. Constitutively present T<sub>reg</sub> are essential for the maintenance of intestinal homeostasis and to control inflammation <xref ref-type="bibr" rid="pone.0071338-Izcue1">[58]</xref>. Especially during inflammation the immunosuppressive function of T<sub>reg</sub> is crucial since a great deal of intestinal pathology originates not from the infection, instead is owing to an overwhelming immune response <xref ref-type="bibr" rid="pone.0071338-Belkaid1">[59]</xref>. In addition, T<sub>reg</sub> cells are of importance since inflammation enhances the ability of enteric pathogens to establish infection <xref ref-type="bibr" rid="pone.0071338-Stecher1">[60]</xref>. Moreover, human IL-10 prevented pathology in <italic>H. pylori</italic> infected <italic>il-10</italic>-deficient mice and is accompanied by an increase in T<sub>reg</sub> cells <xref ref-type="bibr" rid="pone.0071338-Ranatunga1">[61]</xref>. In contrast, during <italic>H. pylori</italic> infection T<sub>reg</sub> cells can be of disadvantage since <italic>H. pylori</italic> manipulates DCs to become tolerant resulting in the induction of regulatory T cells which dampen the immune response and therefore enable long-lasting gastric colonization <xref ref-type="bibr" rid="pone.0071338-Muller1">[62]</xref>. Furthermore, T<sub>reg</sub> cells are important in parasitic infections given that <italic>Toxoplasma gondii</italic> infection-induced pathology <xref ref-type="bibr" rid="pone.0071338-Hall1">[63]</xref> and <italic>Schistosoma mansoni</italic>-caused colonic granulomatous <xref ref-type="bibr" rid="pone.0071338-Turner1">[64]</xref> pathology are attenuated by T<sub>reg</sub> cells. <italic>B. adolescentis</italic> feeding-induced T<sub>reg</sub> cells might dampen intestinal inflammation resulting in unfavorable environmental conditions for <italic>Y. enterocolitica</italic> to establish a systemic infection. <italic>Yersinia pseudotuberculosis</italic> was demonstrated to disseminate directly from the intestinal lumen to the spleen and not to travel via PP and mesenteric lymph nodes <xref ref-type="bibr" rid="pone.0071338-Barnes1">[65]</xref>. In this study reduced inflammation caused by T<sub>reg</sub> cells might maintain intestinal barrier integrity and therefore prevent <italic>Y. enterocolitica</italic> dissemination.</p>
<p>Whether <italic>B. adolescentis</italic> directly interacts with the host mucosal immune system, or whether an indirect effect of <italic>B. adolescentis</italic> reduces the host susceptibility towards <italic>Yersinia</italic> infection by e.g. alteration of the microbiota remains to be elucidated.</p>
<p>Our data provide evidence that commensal <italic>B. adolescentis</italic> increases the frequency of pDC and T<sub>reg</sub> cells and that this might be essential for host resistance to intestinal infection.</p>
</sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pone.0071338.s001" mimetype="application/postscript" xlink:href="info:doi/10.1371/journal.pone.0071338.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><italic>B. adolescentis</italic> Feeding Results in Increased Plasmacytoid DC Frequency. (<bold>A</bold>) Lamina propria dendritic cells (lpDCs) were analyzed by gating on Intraepithelial dendritic cells (ieDC) were analyzed by gating on linage negative (CD3ε, CD19, DX5) and CD11c-positive cells, as demonstrated in exemplarily depicted dot plots. Graph represents mean percentage ± SEM of CD11c<sup>+</sup> lamina propria leukocytes of untreated mock (M, dark gray bar), <italic>B. adolescentis</italic> fed (B, white bar), <italic>Yersinia</italic> infected (Y, black bar), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY, gray bar). (<bold>B</bold>) Histograms represent mean percentage ± SD of CD11b-expressing conventional lpDCs of untreated mock (M), <italic>B. adolescentis</italic> fed (B), <italic>Yersinia</italic> infected (Y), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY) (solid black line) and respective fluorescence minus one control (gray filled histogram). (<bold>C</bold>) CD11c<sup>int</sup> lamina propria dendritic cells (lpDCs) were analyzed by gating on Intraepithelial dendritic cells (ieDC) were analyzed by gating on linage negative (CD3ε, CD19, DX5) and CD11c<sup>int</sup>-positive cells, as demonstrated in exemplarily depicted dot plots. Graph represents mean percentage ± SEM of CD11c<sup>int</sup> lamina propria leukocytes of untreated mock (M, dark gray bar), <italic>B. adolescentis</italic> fed (B, white bar), <italic>Yersinia</italic> infected (Y, black bar), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY, gray bar). Histograms represent mean percentage ± SD of (<bold>D</bold>) B220-expressing and (<bold>E</bold>) PDCA-1-expressing plasmacytoid lpDCs of mock (M), <italic>B. adolescentis</italic> fed (B), <italic>Yersinia</italic> infected (Y), as well as <italic>B. adolescentis</italic> fed and <italic>Yersinia</italic> infected mice (BY) (solid black line) and respective fluorescence minus one control (gray filled histogram). Data represent at least five mice per group.</p>
<p>(EPS)</p>
</caption></supplementary-material><supplementary-material id="pone.0071338.s002" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0071338.s002" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p>Cell Counts of Total Lamina Propria DCs and cDCs (CD11b<sup>+</sup>CD11c<sup>+</sup>).</p>
<p>(DOC)</p>
</caption></supplementary-material><supplementary-material id="pone.0071338.s003" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0071338.s003" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p>Cell Counts of Total Lamina Propria CD11c<sup>int</sup> DCs and pDCs (CD11c<sup>int</sup> B220<sup>+</sup> or mPDCA1<sup>+</sup>).</p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank Frauke Effinger for technical assistance.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0071338-Bottone1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bottone</surname><given-names>EJ</given-names></name> (<year>1999</year>) <article-title>Yersinia enterocolitica: overview and epidemiologic correlates</article-title>. <source>Microbes Infect</source> <volume>1</volume>: <fpage>323</fpage>–<lpage>333</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Cover1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cover</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Aber</surname><given-names>RC</given-names></name> (<year>1989</year>) <article-title>Yersinia enterocolitica</article-title>. <source>NEnglJMed</source> <volume>321</volume>: <fpage>16</fpage>–<lpage>24</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Cornelis1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cornelis</surname><given-names>GR</given-names></name> (<year>1994</year>) <article-title>Yersinia pathogenicity factors</article-title>. <source>CurrTopMicrobiolImmunol</source> <volume>192</volume>: <fpage>243</fpage>–<lpage>263</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Schindler1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schindler</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Schutz</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Muhlenkamp</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Rooijakkers</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Hallstrom</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products</article-title>. <source>J Immunol</source> <volume>189</volume>: <fpage>4900</fpage>–<lpage>4908</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-DeLaCochetiere1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De La Cochetiere</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Durand</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lalande</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Petit</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Potel</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile</article-title>. <source>MicrobEcol</source> <volume>56</volume>: <fpage>395</fpage>–<lpage>402</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Dethlefsen1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dethlefsen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Huse</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Sogin</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Relman</surname><given-names>DA</given-names></name> (<year>2008</year>) <article-title>The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing</article-title>. <source>PLoSBiol</source> <volume>6</volume>: <fpage>e280</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Jernberg1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jernberg</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lofmark</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Edlund</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jansson</surname><given-names>JK</given-names></name> (<year>2007</year>) <article-title>Long-term ecological impacts of antibiotic administration on the human intestinal microbiota</article-title>. <source>ISMEJ</source> <volume>1</volume>: <fpage>56</fpage>–<lpage>66</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Lofmark1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lofmark</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jernberg</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jansson</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Edlund</surname><given-names>C</given-names></name> (<year>2006</year>) <article-title>Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes</article-title>. <source>JAntimicrobChemother</source> <volume>58</volume>: <fpage>1160</fpage>–<lpage>1167</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Antonopoulos1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antonopoulos</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Huse</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Morrison</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Schmidt</surname><given-names>TM</given-names></name>, <name name-style="western"><surname>Sogin</surname><given-names>ML</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation</article-title>. <source>InfectImmun</source> <volume>77</volume>: <fpage>2367</fpage>–<lpage>2375</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Yap1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yap</surname><given-names>IK</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>JV</given-names></name>, <name name-style="western"><surname>Saric</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>FP</given-names></name>, <name name-style="western"><surname>Davies</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Metabonomic and microbiological analysis of the dynamic effect of vancomycin-induced gut microbiota modification in the mouse</article-title>. <source>JProteomeRes</source> <volume>7</volume>: <fpage>3718</fpage>–<lpage>3728</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Sekirov1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sekirov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Russell</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Antunes</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Finlay</surname><given-names>BB</given-names></name> (<year>2010</year>) <article-title>Gut microbiota in health and disease</article-title>. <source>Physiol Rev</source> <volume>90</volume>: <fpage>859</fpage>–<lpage>904</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Lupp1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lupp</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Wickham</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Sekirov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Champion</surname><given-names>OL</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of <italic>Enterobacteriaceae</italic></article-title>. <source>Cell HostMicrobe</source> <volume>2</volume>: <fpage>204</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Brandl1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brandl</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Plitas</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Mihu</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Ubeda</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Vancomycin-resistant <italic>enterococci</italic> exploit antibiotic-induced innate immune deficits</article-title>. <source>Nature</source> <volume>455</volume>: <fpage>804</fpage>–<lpage>807</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Gradel1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gradel</surname><given-names>KO</given-names></name>, <name name-style="western"><surname>Schonheyder</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Kristensen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dethlefsen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ejlertsen</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Are host characteristics or exposure factors mainly involved in the acquisition of zoonotic Salmonella and Campylobacter coinfection in humans?</article-title> <source>FoodbornePathogDis</source> <volume>6</volume>: <fpage>251</fpage>–<lpage>255</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Barthel1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barthel</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hapfelmeier</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Quintanilla-Martinez</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kremer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rohde</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host</article-title>. <source>InfectImmun</source> <volume>71</volume>: <fpage>2839</fpage>–<lpage>2858</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Frick1"><label>16</label>
<mixed-citation publication-type="other" xlink:type="simple">Frick JS, Autenrieth IB (2012) The Gut Microflora and Its Variety of Roles in Health and Disease. Curr Top Microbiol Immunol.</mixed-citation>
</ref>
<ref id="pone.0071338-Senok1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Senok</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Ismaeel</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Botta</surname><given-names>GA</given-names></name> (<year>2005</year>) <article-title>Probiotics: facts and myths</article-title>. <source>ClinMicrobiolInfect</source> <volume>11</volume>: <fpage>958</fpage>–<lpage>966</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Gionchetti1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gionchetti</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Rizzello</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Venturi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Campieri</surname><given-names>M</given-names></name> (<year>2000</year>) <article-title>Probiotics in infective diarrhoea and inflammatory bowel diseases</article-title>. <source>JGastroenterolHepatol</source> <volume>15</volume>: <fpage>489</fpage>–<lpage>493</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Weichert1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weichert</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Schroten</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>R</given-names></name> (<year>2012</year>) <article-title>The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases</article-title>. <source>Pediatr Infect Dis J</source> <volume>31</volume>: <fpage>859</fpage>–<lpage>862</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Canani1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Canani</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Cirillo</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Terrin</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Cesarano</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Spagnuolo</surname><given-names>MI</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations</article-title>. <source>BMJ</source> <volume>335</volume>: <fpage>340</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Nomoto1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nomoto</surname><given-names>K</given-names></name> (<year>2005</year>) <article-title>Prevention of infections by probiotics</article-title>. <source>JBiosciBioeng</source> <volume>100</volume>: <fpage>583</fpage>–<lpage>592</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Schlitzer1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlitzer</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Heiseke</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Einwachter</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Reindl</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Schiemann</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor</article-title>. <source>Blood</source> <volume>119</volume>: <fpage>6063</fpage>–<lpage>6071</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Iwasaki1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iwasaki</surname><given-names>A</given-names></name> (<year>2007</year>) <article-title>Mucosal dendritic cells</article-title>. <source>Annual review of immunology</source> <volume>25</volume>: <fpage>381</fpage>–<lpage>418</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Kraehenbuhl1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kraehenbuhl</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Neutra</surname><given-names>MR</given-names></name> (<year>2000</year>) <article-title>Epithelial M cells: differentiation and function</article-title>. <source>Annual review of cell and developmental biology</source> <volume>16</volume>: <fpage>301</fpage>–<lpage>332</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Niess1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Niess</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Brand</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Landsman</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance</article-title>. <source>Science</source> <volume>307</volume>: <fpage>254</fpage>–<lpage>258</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Bogunovic1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bogunovic</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ginhoux</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Helft</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Shang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Hashimoto</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Origin of the lamina propria dendritic cell network</article-title>. <source>Immunity</source> <volume>31</volume>: <fpage>513</fpage>–<lpage>525</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-delRio1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>del Rio</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Bernhardt</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Rodriguez-Barbosa</surname><given-names>JI</given-names></name>, <name name-style="western"><surname>Forster</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>Development and functional specialization of CD103+ dendritic cells</article-title>. <source>Immunol Rev</source> <volume>234</volume>: <fpage>268</fpage>–<lpage>281</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Wendland1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wendland</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Czeloth</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mach</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Malissen</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kremmer</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>104</volume>: <fpage>6347</fpage>–<lpage>6352</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Villadangos1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Villadangos</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>L</given-names></name> (<year>2008</year>) <article-title>Antigen-presentation properties of plasmacytoid dendritic cells</article-title>. <source>Immunity</source> <volume>29</volume>: <fpage>352</fpage>–<lpage>361</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Baumgart1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baumgart</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Metzke</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Guckelberger</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Pascher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Grotzinger</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis</article-title>. <source>Clin Exp Immunol</source> <volume>166</volume>: <fpage>46</fpage>–<lpage>54</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Moseman1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moseman</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Dawson</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Panoskaltsis-Mortari</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Krieg</surname><given-names>AM</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells</article-title>. <source>JImmunol</source> <volume>173</volume>: <fpage>4433</fpage>–<lpage>4442</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Matta1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matta</surname><given-names>BM</given-names></name>, <name name-style="western"><surname>Castellaneta</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Thomson</surname><given-names>AW</given-names></name> (<year>2010</year>) <article-title>Tolerogenic plasmacytoid DC</article-title>. <source>Eur J Immunol</source> <volume>40</volume>: <fpage>2667</fpage>–<lpage>2676</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Frick2"><label>33</label>
<mixed-citation publication-type="other" xlink:type="simple">Frick JS, Fink K, Kahl F, Niemiec MJ, Quitadamo M, <etal>et al</etal>.. (2007) Identification of commensal bacterial strains modulating Yersinia and DSS-induced inflammatory responses: implications for the development of probiotics. InfectImmun.</mixed-citation>
</ref>
<ref id="pone.0071338-Autenrieth1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Autenrieth</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Beer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bohn</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kaufmann</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Heesemann</surname><given-names>J</given-names></name> (<year>1994</year>) <article-title>Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon</article-title>. <source>Infect Immun</source> <volume>62</volume>: <fpage>2590</fpage>–<lpage>2599</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Hadeiba1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hadeiba</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Habtezion</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Oderup</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease</article-title>. <source>Nature immunology</source> <volume>9</volume>: <fpage>1253</fpage>–<lpage>1260</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Sekirov2"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sekirov</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Tam</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Jogova</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Robertson</surname><given-names>ML</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Antibiotic-induced perturbations of the intestinal microbiota alter host susceptibility to enteric infection</article-title>. <source>Infection and immunity</source> <volume>76</volume>: <fpage>4726</fpage>–<lpage>4736</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Lawley1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lawley</surname><given-names>TD</given-names></name>, <name name-style="western"><surname>Clare</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Stares</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Connor</surname><given-names>TR</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice</article-title>. <source>PLoS Pathog</source> <volume>8</volume>: <fpage>e1002995</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Cummings1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cummings</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Pomare</surname><given-names>EW</given-names></name>, <name name-style="western"><surname>Branch</surname><given-names>WJ</given-names></name>, <name name-style="western"><surname>Naylor</surname><given-names>CP</given-names></name>, <name name-style="western"><surname>Macfarlane</surname><given-names>GT</given-names></name> (<year>1987</year>) <article-title>Short chain fatty acids in human large intestine, portal, hepatic and venous blood</article-title>. <source>Gut</source> <volume>28</volume>: <fpage>1221</fpage>–<lpage>1227</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Maslowski1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Maslowski</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Vieira</surname><given-names>AT</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kranich</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sierro</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43</article-title>. <source>Nature</source> <volume>461</volume>: <fpage>1282</fpage>–<lpage>1286</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Fukuda1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fukuda</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Toh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Hase</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Oshima</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Nakanishi</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Bifidobacteria can protect from enteropathogenic infection through production of acetate</article-title>. <source>Nature</source> <volume>469</volume>: <fpage>543</fpage>–<lpage>547</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Bansal1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bansal</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Alaniz</surname><given-names>RC</given-names></name>, <name name-style="western"><surname>Wood</surname><given-names>TK</given-names></name>, <name name-style="western"><surname>Jayaraman</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source> <volume>107</volume>: <fpage>228</fpage>–<lpage>233</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Cario1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cario</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gerken</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Podolsky</surname><given-names>DK</given-names></name> (<year>2004</year>) <article-title>Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology</article-title>. <volume>127</volume>: <fpage>224</fpage>–<lpage>238</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Yan1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yan</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Cover</surname><given-names>TL</given-names></name>, <name name-style="western"><surname>Whitehead</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Washington</surname><given-names>MK</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth</article-title>. <source>Gastroenterology</source> <volume>132</volume>: <fpage>562</fpage>–<lpage>575</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Kim1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Whang</surname><given-names>KY</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YJ</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>S</given-names></name> (<year>2008</year>) <article-title>Inhibition of Escherichia coli O157: H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells</article-title>. <source>Journal of microbiology and biotechnology</source> <volume>18</volume>: <fpage>1278</fpage>–<lpage>1285</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Otte1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Otte</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Podolsky</surname><given-names>DK</given-names></name> (<year>2004</year>) <article-title>Functional modulation of enterocytes by gram-positive and gram-negative microorganisms</article-title>. <source>American journal of physiology Gastrointestinal and liver physiology</source> <volume>286</volume>: <fpage>G613</fpage>–<lpage>626</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Wehkamp1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wehkamp</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Harder</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wehkamp</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Wehkamp-von</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Schlee</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium</article-title>. <source>InfectImmun</source> <volume>72</volume>: <fpage>5750</fpage>–<lpage>5758</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Kinnebrew1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kinnebrew</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Buffie</surname><given-names>CG</given-names></name>, <name name-style="western"><surname>Diehl</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Zenewicz</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Leiner</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense</article-title>. <source>Immunity</source> <volume>36</volume>: <fpage>276</fpage>–<lpage>287</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Murphy1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murphy</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Cotter</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Hogan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>O'Sullivan</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Joyce</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity</article-title>. <source>Gut</source> <volume>62</volume>: <fpage>220</fpage>–<lpage>226</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Mazmanian1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mazmanian</surname><given-names>SK</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>CH</given-names></name>, <name name-style="western"><surname>Tzianabos</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Kasper</surname><given-names>DL</given-names></name> (<year>2005</year>) <article-title>An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system</article-title>. <source>Cell</source> <volume>122</volume>: <fpage>107</fpage>–<lpage>118</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Fujiwara1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fujiwara</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Presley</surname><given-names>LL</given-names></name>, <name name-style="western"><surname>Brewer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>McPherson</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Systemic control of plasmacytoid dendritic cells by CD8+ T cells and commensal microbiota</article-title>. <source>Journal of immunology</source> <volume>180</volume>: <fpage>5843</fpage>–<lpage>5852</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Diana1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Diana</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Griseri</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lagaye</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Beaudoin</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Autrusseau</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner</article-title>. <source>Immunity</source> <volume>30</volume>: <fpage>289</fpage>–<lpage>299</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Contractor1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Contractor</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Louten</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Biron</surname><given-names>CA</given-names></name>, <name name-style="western"><surname>Kelsall</surname><given-names>BL</given-names></name> (<year>2007</year>) <article-title>Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype</article-title>. <source>Journal of immunology</source> <volume>179</volume>: <fpage>2690</fpage>–<lpage>2694</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Katakura1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Katakura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Rachmilewitz</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Eckmann</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Toll-like receptor 9-induced type I IFN protects mice from experimental colitis</article-title>. <source>JClinInvest</source> <volume>115</volume>: <fpage>695</fpage>–<lpage>702</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-McFarland1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McFarland</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Savan</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Wagage</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Addison</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ramakrishnan</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Localized delivery of interferon-beta by Lactobacillus exacerbates experimental colitis</article-title>. <source>PloS one</source> <volume>6</volume>: <fpage>e16967</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Yen1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yen</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ganea</surname><given-names>D</given-names></name> (<year>2010</year>) <article-title>IFN-beta inhibits dendritic cell migration through STAT-1-mediated transcriptional suppression of CCR7 and matrix metalloproteinase 9</article-title>. <source>Journal of immunology</source> <volume>184</volume>: <fpage>3478</fpage>–<lpage>3486</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Farache1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Farache</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Koren</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Milo</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Gurevich</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>KW</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation</article-title>. <source>Immunity</source> <volume>38</volume>: <fpage>581</fpage>–<lpage>595</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Ito1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ito</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>YH</given-names></name>, <name name-style="western"><surname>Lande</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gregorio</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand</article-title>. <source>JExpMed</source> <volume>204</volume>: <fpage>105</fpage>–<lpage>115</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Izcue1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Izcue</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Coombes</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Powrie</surname><given-names>F</given-names></name> (<year>2009</year>) <article-title>Regulatory lymphocytes and intestinal inflammation</article-title>. <source>Annual review of immunology</source> <volume>27</volume>: <fpage>313</fpage>–<lpage>338</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Belkaid1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Belkaid</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Tarbell</surname><given-names>K</given-names></name> (<year>2009</year>) <article-title>Regulatory T cells in the control of host-microorganism interactions (*)</article-title>. <source>Annual review of immunology</source> <volume>27</volume>: <fpage>551</fpage>–<lpage>589</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Stecher1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stecher</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Robbiani</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Walker</surname><given-names>AW</given-names></name>, <name name-style="western"><surname>Westendorf</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Barthel</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota</article-title>. <source>PLoS biology</source> <volume>5</volume>: <fpage>2177</fpage>–<lpage>2189</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Ranatunga1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ranatunga</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Ramakrishnan</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Uprety</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>A protective role for human IL-10-expressing CD4+ T cells in colitis</article-title>. <source>Journal of immunology</source> <volume>189</volume>: <fpage>1243</fpage>–<lpage>1252</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Muller1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muller</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Oertli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>IC</given-names></name> (<year>2011</year>) <article-title>H. pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection</article-title>. <source>Cell communication and signaling: CCS</source> <volume>9</volume>: <fpage>25</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Hall1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hall</surname><given-names>AO</given-names></name>, <name name-style="western"><surname>Beiting</surname><given-names>DP</given-names></name>, <name name-style="western"><surname>Tato</surname><given-names>C</given-names></name>, <name name-style="western"><surname>John</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Oldenhove</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology</article-title>. <source>Immunity</source> <volume>37</volume>: <fpage>511</fpage>–<lpage>523</lpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Turner1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turner</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Hogg</surname><given-names>KG</given-names></name>, <name name-style="western"><surname>Aynsley</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Paveley</surname><given-names>RA</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection</article-title>. <source>PLoS neglected tropical diseases</source> <volume>5</volume>: <fpage>e1269</fpage>.</mixed-citation>
</ref>
<ref id="pone.0071338-Barnes1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barnes</surname><given-names>PD</given-names></name>, <name name-style="western"><surname>Bergman</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Mecsas</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Isberg</surname><given-names>RR</given-names></name> (<year>2006</year>) <article-title>Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine</article-title>. <source>JExpMed</source> <volume>203</volume>: <fpage>1591</fpage>–<lpage>1601</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>